ISTH Criteria for Disseminated Intravascular Coagulation

The ISTH DIC criteria use platelet count, PT prolongation, fibrin‑related markers, and fibrinogen level to generate a score indicating overt consumptive coagulopathy.

Platelet count, cells x 10^9/L
≥ 100050 to < 100+1< 50+2
Elevated levels of a fibrin-related marker
No increase0Moderate increase+2Severe increase+3
Prolonged PT, seconds
< 303 to < 6+1≥ 6+2
Fibrinogen level, g/L
≥ 10< 1+1

Indications for Use

Used when DIC is clinically suspected in sepsis, trauma, malignancy, obstetric catastrophe, or shock to determine presence/severity of consumptive coagulopathy. Helps distinguish overt vs evolving DIC, guides urgency of treating the underlying trigger, and supports decisions on blood product use in bleeding or high‑risk patients. Serial scoring tracks dynamic changes and correlates with morbidity and mortality to identify patients at highest risk who may warrant closer monitoring or targeted intervention.

Insights & Cautions

Start with platelet count, PT prolongation, fibrin‑related marker elevation, and low fibrinogen to detect consumptive coagulopathy, but interpret trends over time. Cautions: limited specificity, especially in cirrhosis where similar abnormalities arise without true DIC 1. High D‑dimer is sensitive but nonspecific; cutoffs vary by assay. Early or “compensated” DIC may be missed, prompting use of SIC in sepsis 2. The score guides recognition, not etiology or therapy.